Sentynl Therapeutics, Inc. Employee Directory

Q: How many employees does Sentynl Therapeutics, Inc. have currently?

Sentynl Therapeutics, Inc. has approximately 24 employees.

Q: Who are Sentynl Therapeutics, Inc.'s key employees and leadership?

Sentynl Therapeutics, Inc.'s key employees include: Executive Vice President & Chief Financial Officer: D. S., Co-Founder And Chief Operations Officer: D. P..

Pharmaceutical ManufacturingCalifornia, United States11-50 Employees

Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.

Find Sentynl Therapeutics, Inc. employees' phone numbers or email addresses

Sentynl Therapeutics, Inc. Global Highlights

North America
49

United States Of America
49

Asia
4

India
4

Sentynl Therapeutics, Inc.'s Leadership

D. P.
Co-Founder And Chief Operations Officer
Mobile Phone
Email
D. S.
Executive Vice President & Chief Financial Officer
Mobile Phone
Email
G. C.
Senior Vice President Commercial Strategy & Operations
Mobile Phone
Email
J. R.
Senior Vice President & Head Of Medical Affairs
Mobile Phone
Email
M. C.
Senior Director Of Rare Disease Marketing
Mobile Phone
Email
L. D.
Senior Director Medical Affairs
Mobile Phone
Email
C. K.
Information Technology Director
Mobile Phone
Email
Y. B.
Associate Director Human Resources And Payroll
Mobile Phone
Email

Contact profiles from Sentynl Therapeutics, Inc.

Name

Title

Contact Info

Location

Last Update

L. S.
Key Account Specialist
Mobile Phone
Email
Oct 16, 2024
M. W.
Key Account Specialist
Mobile Phone
Email
UNITED STATES
Oct 16, 2024
M. H.
Key Account Specialist
Mobile Phone
Email
Oct 17, 2024
N. J.
Key Account Specialist
Mobile Phone
Email
United StatesMaryland
Oct 17, 2024
N. N.
Key Account Specialist
Mobile Phone
Email
UNITED STATES
Aug 04, 2023
V. P.
Key Account Specialist
Mobile Phone
Email
United StatesFlorida
Oct 21, 2024
D. L.
Key Account Specialist
Mobile Phone
Email
United StatesNorth Carolina
Oct 13, 2025
D. P.
Mobile Phone
Email
UNITED STATES
Mar 07, 2023
J. M.
Mobile Phone
Email
UNITED STATES
Mar 07, 2023
L. H.
Mobile Phone
Email
UNITED STATES
Mar 07, 2023

Frequently Asked Questions

What is Sentynl Therapeutics, Inc. known for?

Sentynl Therapeutics, Inc. operates in the Pharmaceutical Manufacturing industry. The company's main headquarters is located in 420 Stevens Avenue, Suite 200; you can contact the main corporate office by phone at

+1-858-720-****

. Explore Sentynl Therapeutics, Inc.'s company overview page for more information.

What is Sentynl Therapeutics, Inc.'s most common email format?

Sentynl Therapeutics, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Sentynl Therapeutics, Inc. email formats with LeadIQ.

How many employees does Sentynl Therapeutics, Inc. have currently?

Sentynl Therapeutics, Inc. has approximately 24 employees as of December 2025. These team members are located across 2 continents, including North AmericaAsia.

Who are Sentynl Therapeutics, Inc.'s key employees and leadership?

As of December 2025, Sentynl Therapeutics, Inc.'s key employees include:

Co-Founder And Chief Operations Officer: D. P.
Executive Vice President & Chief Financial Officer: D. S.
Senior Vice President Commercial Strategy & Operations: G. C.
Senior Vice President & Head Of Medical Affairs: J. R.
Senior Director Of Rare Disease Marketing: M. C.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.